← Back
$GALT All transactions

GALECTIN THERAPEUTICS INC

M 10b5-1 Plan

$ Value

$2K

Shares

1,736

Price

$1

Filed

Nov 12

Insider

Name

CALLICUTT JACK W

Title

Chief Financial Officer

CIK

0001266773

Roles

Officer

Transaction Details

Transaction Date

2025-11-10

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

9,350

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025. | The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023. | The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024. | The options vests as follows: 25% on June 30, 2025, with 25% scheduled to vest on each of December 31, 2025, June 30, 2026, on December 31, 2026. | The shares were sold in multiple transactions at prices ranging from $6.00 to $6.14. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Filing Info

Accession No.

0001133416-25-000050

Form Type

4

Issuer CIK

0001133416

CALLICUTT JACK W's History

Date Ticker Type Value
2026-01-16 GALT A $0
2026-01-16 GALT A $0
2026-01-06 GALT $75K
2026-01-05 GALT $100K
2026-01-02 GALT M $0
2026-01-02 GALT $58K
2026-01-01 GALT M $0
2025-11-18 GALT M $56K
2025-11-18 GALT $175K
2025-11-18 GALT M $20K

Other Insiders at GALT (90d)

Insider Bought Sold Last
ELDRED KARY $810 2026-02-06
Brem Henry 2026-03-12